The Institute for Healthier Living Abu Dhabi is sponsoring the 12th Aging Research & Drug Discovery Meeting, a global conference on aging research. IHLAD will present its approach to advancing healthspan through keynotes and strategic briefings.
Human Longevity, Inc., a leading longevity company, sponsors ARDD 2025, sharing new insights on genomic and multi-imaging-based risk detection. The event brings together academia, pharma, and investors to discuss aging research and its translation into life-extending care.
Longevity Investors, a premier platform for longevity investment and scientists, sponsors ARDD 2025 alongside Nobel laureates and industry leaders. The conference will foster collaboration and showcase groundbreaking research in aging biotechnology.
Haut.AI will showcase its latest generative AI technology at the 12th Aging Research & Drug Discovery Meeting, enabling simulation of aging trajectories and supporting scientific exploration of visual biomarkers in aging. The company's AI systems are trusted by over 100 organizations globally.
DEZAWA MUSE Cells have the unique ability to focus on areas of damage and naturally differentiate into specific cells needed for repair. MUSECell Innovations is leading regenerative medicine with innovative therapies like DEZAWA GOLDEN IV, combining cells with advanced delivery technologies.
Gordian Biotechnology, a therapeutics company, will sponsor ARDD 2025, showcasing its lead program for osteoarthritis and advancing targets using gene therapy. The company's discovery platform enables early evaluation of therapeutic candidates in complex disease models.
Rejuve.Bio will sponsor ARDD 2025, a premier conference on aging research, to advance drug discovery for healthy longevity. The event brings together world-class researchers, clinicians, and innovators to discuss cutting-edge solutions for age-related diseases.
NADMED will showcase its advanced tests at ARDD 2025, highlighting the role of NAD in metabolism, cellular repair, and longevity. The company's technology empowers scientists and clinicians with reliable data to develop targeted therapies and interventions.
ARDD 2025 to feature Nobel laureates and pharmaceutical industry executives discussing cutting-edge aging research and clinical applications. The event aims to advance healthspan and longevity science through evidence-based approaches.
The University of Copenhagen announces Immortal Dragons as a Tier 4 sponsor of the upcoming ARDD 2025 conference. The fund supports moonshot longevity startups in areas like wholebody replacement, gene therapy, and special economic zones. Nobel laureates will also be featured at the event.
ARDD 2025 will feature cutting-edge research and clinical applications in healthy longevity medicine. Mitra Bio's sponsorship aims to support longevity science community and share insights from its skin aging space expertise.
The University of Copenhagen is excited to announce Zuber Lawler as a sponsor of the 12th Aging Research & Drug Discovery Meeting. The conference will bring together academia-pharma-startup-investor partnerships to discuss advancements in aging research and its applications.
Deep Origin will host two presentations at ARDD 2025, showcasing its AI-based models for drug discovery and longevity. The company aims to enable creation of virtual cells and deeper understanding of biological function.
Repair Biotechnologies develops therapies targeting toxic excess free cholesterol in cells, a hallmark of aging and obesity. The company is advancing a lead drug for accelerated atherosclerosis, with ARDD providing opportunities to connect with brilliant minds and showcase groundbreaking research.
LongGame Ventures supports cutting-edge research in longevity biotechnology at ARDD 2025, featuring Nobel laureates and industry leaders. The conference aims to advance healthspan and longevity science, with a focus on regenerative medicine and cellular replacement.
ARDD 2025 to feature Nobel laureates and pharmaceutical executives discussing latest advancements in aging research. Maxwell Biosciences will showcase its CLAROMER technology enhancing innate immune system, promoting healthy longevity.
TruDiagnostic presents its latest advancements in epigenetic testing, leveraging DNA methylation to predict disease risk. The company has developed over 1,700 Epigenetic Biomarker Proxies (EBPs), outperforming traditional biomarkers in accuracy and effectiveness.
The Aging Research and Drug Discovery Meeting (ARDD2025) will feature Nobel laureates Morten Meldal and Michael Levitt. Their groundbreaking discoveries have had a lasting impact on drug development and molecular design, highlighting the conference's pivotal role in advancing healthspan and longevity science.